Your AI platform for disease and drug research

AI-integrated knowledge base

We make our AI integrated knowledge base directly available to researchers and enable intelligent and proactive Search, powerful and intuitive Analytics, visualized low-bias Relation Maps and many highly effective workflows.

Intelligent and proactive Search
Powerful and intuitive Analytics
Visualized low-bias Relation Maps
Highly effective Workflows
Euretos
Search

Intelligent and proactive Search

Our AI driven search engine automatically includes all synonyms of your search terms and finds database entries that Google can’t display. It gives you a list of all related terms to your query in 100+ categories, ranked on number of references. It interprets your queries and provides suggestions for what to explore next.

- Target Analysis

- Gene-Disease Analysis

- Set Creation. 

Euretos
Analytics

Powerful and intuitive Analytics

Euretos Analytics evaluates your experimental data against the entire knowledge base. It combines sets to create informative set overlays. These sets can either be uploaded by you or created using Search. It analyzes and ranks these overlays giving you new insights into underlying common factors, differentiators and associations.

Gene Set Enrichment

Gene Set Ranking

Transcription Network Analysis

Enabling world leading pharma, biotech and academic institutions
Logo Genmab-2
Janssen and Janssen Pharmaceutical Companies
Leiden Academic Centre for Drug Research
Astra Zeneca
Boehringer Ingelheim
Tufts University
Euretos
Relation Map

Visualized, low-bias Relation Maps

The Relation Map visualizes relations from databases, such as molecular interactions, expression values and human annotations. These visual maps enable unique, low-bias insights such as term clustering, indirect associations and term centrality. This way you can test your hypothesis, create your own disease models and share these as powerful visualizations.
Euretos
Target Discovery

Target Discovery in cancer

We have created powerful workflows to discover targets in oncology for compounds, antibodies and bispecific antibodies. These enable you to discover targets with high tumor expression and low expression in normal tissues to find selective, tumor specific targets.

Target Discovery for Cancer

Target Discovery for Bispecific Antibodies.

Euretos Indication Expansion
Customer review

Indication Expansion/Drug Repurposing

"In this project we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities."

Global Head R&D Innovation Large European Pharma
Euretos Patient Stratification and drug response analysis
Customer review

Drug Response & Efficacy

"it really does show the value of having an independent set of eyes interpreting the data that we all have been staring at for years."

Principal Scientist Large US Pharma
Euretos Safety & Toxicity Analysis
Customer review

Toxicity Analysis

"The proposed mechanism of action was very attractive. The Euretos team helped to explain the phenomenon as it was observed in mouse studies. We are very grateful for this report which has provided us with a lot of very useful information."

Principal Scientist Large Japanese Pharma
Euretos Target discovery
Customer review

Target Discovery

"We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI Platform is a mandatory input to our target evaluation meetings"

Director Target Discovery Large European Biotech
Enabling world leading pharma, biotech and academic institutions
Logo Johnson & Johnson-2
Logo Grunenthal-2
Logo Daiichi Sankyo-1
Logo Pivot Park-1
Logo Sanofi
Logo EMC

Transforming Disease and Drug Research

Get started Start your trial now!
Book a demo